Argentina Develops Cheaper Biosimilar Cancer Drug

Argentina has developed a more affordable biosimilar version of a leading cancer drug, a move attributed to strict patent regulations that are now being observed by pharmaceutical companies and states globally.

25 Apr, 12:18 — 25 Apr, 12:18

Post Share

Sources

Showing 1 of 1 sources

buenos-aires-heraldMostly Factual128d ago

How Argentina created a cheaper version of a top cancer drug. Can others follow?

Strict patent regulations — now loosened by Milei — led to a biosimilar that pharmaceuticals and states are watching with interest La entrada How Argentina created a cheaper version of a top cancer drug. Can others follow? se publicó primero en Buenos Aires Herald.

By Veronica Smink

Read full article →

Argentina Develops Cheaper Biosimilar Cancer Drug

Sources

How Argentina created a cheaper version of a top cancer drug. Can others follow?

Related Stories

Lionel Richie Hospitalized in ICU Following St. Louis Concert

Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue

Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases

England Pharmacies to Offer Free Quick Cholesterol Screening Tests